M

matookerepublic.com

@matookerepublic Tue, 14 Jul 2026 01:04:00

50 healthy volunteers aged 18–55 needed for first Bundibugyo Ebola Vaccine trial

The University of Oxford has launched the first human trial of a new vaccine designed to protect against Bundibugyo ebolavirus, as scientists race to develop a vaccine for the strain responsible for the ongoing Ebola outbreak. The Phase I clinical trial will involve 50 healthy volunteers aged between 18 and 55 and will be carried The post 50 healthy volunteers aged 18–55 needed for first Bundibugyo Ebola Vaccine trial first appeared on Matooke Republic.

read more

Other Headlines